Dr. Lal Path Labs Share Price

NSE: LALPATHLAB

₹ 1,759.20

+₹72.10 (4.27%)

Last updated 24 Jul, 2026, 15:47 IST

Dr. Lal Path Labs Share Price Today

As of 25 Jul 2026, Dr. Lal Path Labs share price is ₹1,759.20. The stock opened at ₹1,670.20, compared to its previous close of ₹1,687.10. During today's trading session, Dr. Lal Path Labs share price moved in the range of ₹1,650.90 to ₹1,791.40, with an average price of ₹1,721.15 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,272.60 and a high of ₹1,803.00. On the performance front, Dr. Lal Path Labs share price has increased by 27.81% over the last six months and is up 13.76% on a year-on-year basis.

₹1,650.90

4.27% up today

₹1,791.40

1D LOW

1D HIGH

Latest Earning

Op Profit TrendUp by 42.85% QoQ

Latest Earning

Net Profit TrendUp by 28.97% QoQ

Latest Earning

Revenue TrendUp by 14.16% QoQ

Stock Performance

OutperformingBeat Nifty by 0.86 % in last 1 month

Shareholding Pattern

PromoterPromoter decreased stake by 0.05%

Shareholding Pattern

DIIDII increased stake by 1.55%

Shareholding Pattern

FIIFII increased stake by 1.02%

Dr. Lal Path Labs Returns Calculator

If you would've invested

₹

₹1,000₹1Cr

Historical Returns

1 Year

₹5,71,689+₹71,689 (+14.34%)

3 Year

₹7,56,190+₹2,56,190 (+51.24%)

5 Year

₹4,94,658-₹5,342 (-1.07%)

₹1,407.40₹2,111.00

Circuit Low

Circuit High

₹1,272.60₹1,803.00

52-Week Low

52-Week High

Circuit

₹1,407.40

₹2,111.00

52-week

₹1,272.60

₹1,803.00

Mkt Cap Cr

28,275.50

P/E

43.61

P/B

8.78

ROE

21.78%

D/E

0.07

ROCE

27.45%

Div. Yield

1.56%

EPS(TTM)

30.45

Turnover

1.01

EV/EBITDA

24.96

Net Margin

19.20%

Op. Margin

31.59%

ROA

18.40%

Quick Ratio

3.35

Curr. Ratio

2.70

Mkt Cap Cr

28,275.50

P/E

43.61

P/B

8.78

ROE

21.78%

D/E

0.07

ROCE

27.45%

Div. Yield

1.56%

EPS(TTM)

30.45

Turnover

1.01

EV/EBITDA

24.96

Net Margin

19.20%

Op. Margin

31.59%

ROA

18.40%

Quick Ratio

3.35

Curr. Ratio

2.70

Based on fundamentals, this stock's

Performance

Excellent

Dr Lal Pathlabs outperforming all market indices

Valuation

Fairly Valued

Dr Lal Pathlabs appears to be fairly valued compared to its peers

Earnings

Excellent

Dr Lal Pathlabs revenue, operating profit and net profit are growing

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROE	D/E	ROCE	Book Value	Div. Yield	Turnover	EPS(TTM)
Apollo Hospitals	1,26,592.00	63.76	13.48	20.48%	0.32	17.27%	692.92	0.23%	0.70	103.81
Max Healthcare	1,05,256.00	64.89	8.71	14.33%	0.08	13.72%	10.47	0.21%	0.28	7.37
Fortis Healthcare	71,354.90	57.58	6.06	11.31%	0.22	13.36%	6.50	0.13%	0.16	3.05
Aster DM Healthcare	68,387.10	160.00	14.92	8.48%	0.31	10.10%	53.53	0.23%	0.46	5.20
Narayana Hrudayalaya	40,457.30	50.20	8.92	17.76%	0.76	11.42%	127.10	0.23%	0.85	24.77
Global Health	36,944.30	66.67	9.33	14.05%	0.06	15.26%	149.24	0.04%	0.77	18.46
KRISHNA INST OF MED SCI L	32,838.20	138.41	8.94	10.74%	0.63	7.99%	93.54	0.00%	0.46	6.52
Poly Medicure	16,538.80	51.57	5.32	10.37%	0.08	12.71%	301.18	0.21%	0.53	33.15
Syngene International	16,413.20	49.65	3.25	7.78%	0.05	9.52%	3.34	0.32%	0.67	7.58
DR AGARWALS HEALTH CARE L	15,153.80	90.19	7.48	6.58%	0.34	9.75%	62.81	0.00%	0.49	1.25

Dr. Lal Path Labs Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Revenue	₹2,762.91	₹2,461.40	₹2,226.64	₹2,016.88
Other Income	₹101.27	₹93.43	₹69.17	₹41.72
Total Revenue	₹2,864.18	₹2,554.83	₹2,295.81	₹2,058.60
Total Expenses	₹2,165.00	₹1,930.03	₹1,790.36	₹1,714.77
Profit Before Tax	₹669.09	₹624.80	₹505.45	₹343.83
Tax	₹159.33	₹132.55	₹143.16	₹102.75
Profit After Tax	₹509.75	₹492.25	₹362.29	₹241.08
EPS - Basic	₹30.24	₹58.48	₹43.05	₹28.82
EPS - Diluted	₹30.20	₹58.40	₹42.98	₹28.74

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Profit before tax	₹509.75	₹492.25	₹362.29	₹241.08
Income before WC changes	₹784.37	₹731.66	₹631.63	₹526.99
Change in Assets	-₹37.43	-₹17.61	-₹12.84	₹25.09
Change in Liabilities	₹64.05	₹18.73	₹48.58	₹10.38
Change in WC	₹26.62	₹1.12	₹35.74	₹35.48
Cash flow from Operations	₹635.61	₹568.89	₹535.33	₹456.03
Cash flow from Investing	-₹421.86	-₹303.16	-₹24.27	-₹287.31
Cash flow from Financing	-₹263.57	-₹334.03	-₹413.86	-₹283.18
Total Cash Flow	-₹49.83	-₹68.31	₹97.20	-₹114.46
Cash (Start of the year)	₹292.63	₹360.93	₹263.73	₹378.20
Cash (End of the year)	₹242.80	₹292.63	₹360.93	₹263.73

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Non-Current Assets	₹1,579.50	₹1,353.28	₹1,329.27	₹1,412.48
Current Assets	₹1,566.49	₹1,363.51	₹1,126.70	₹973.09
Total Assets	₹3,146.00	₹2,716.79	₹2,455.96	₹2,385.56
Current Liabilities	₹450.62	₹402.35	₹465.19	₹469.75
Net Current Asset	₹1,115.88	₹961.16	₹661.51	₹503.33
Non-Current Liabilities	₹154.10	₹107.96	₹105.41	₹216.26
Equity Capital	₹2,541.28	₹2,206.48	₹1,885.36	₹1,699.55
Total Equity & Liabilities	₹3,146.00	₹2,716.79	₹2,455.96	₹2,385.56

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Revenue	₹2,647.57	₹2,351.62	₹2,125.06	₹1,769.03
Other Income	₹112.74	₹111.52	₹66.30	₹46.60
Total Revenue	₹2,760.31	₹2,463.14	₹2,191.37	₹1,815.63
Total Expenses	₹2,069.97	₹1,841.86	₹1,708.84	₹1,424.80
Profit Before Tax	₹660.25	₹621.28	₹482.53	₹390.83
Tax	₹152.04	₹124.02	₹135.80	₹98.47
Profit After Tax	₹508.21	₹497.27	₹346.73	₹292.36
EPS - Basic	₹30.45	₹29.85	₹41.72	₹35.28
EPS - Diluted	₹30.40	₹29.81	₹41.66	₹35.17

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Profit before tax	₹508.21	₹497.27	₹346.73	₹292.36
Income before WC changes	₹755.46	₹700.92	₹602.75	₹487.14
Change in Assets	-₹44.63	-₹24.29	-₹18.35	₹19.61
Change in Liabilities	₹61.66	₹18.00	₹48.02	₹19.91
Change in WC	₹17.03	-₹6.29	₹29.67	₹39.52
Cash flow from Operations	₹605.87	₹540.00	₹504.60	₹427.53
Cash flow from Investing	-₹382.09	-₹293.00	₹1.17	-₹288.47
Cash flow from Financing	-₹255.95	-₹324.75	-₹410.53	-₹270.05
Total Cash Flow	-₹32.17	-₹77.75	₹95.24	-₹130.99
Cash (Start of the year)	₹266.60	₹344.34	₹249.10	₹351.31
Cash (End of the year)	₹234.43	₹266.60	₹344.34	₹220.32

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Non-Current Assets	₹1,554.56	₹1,343.67	₹1,312.77	₹1,510.00
Current Assets	₹1,494.59	₹1,277.28	₹1,036.39	₹810.17
Total Assets	₹3,049.15	₹2,620.95	₹2,349.16	₹2,320.17
Current Liabilities	₹434.44	₹388.44	₹450.47	₹432.16
Net Current Asset	₹1,060.16	₹888.85	₹585.92	₹378.01
Non-Current Liabilities	₹141.89	₹98.28	₹97.97	₹198.15
Equity Capital	₹2,472.83	₹2,134.23	₹1,800.72	₹1,689.86
Total Equity & Liabilities	₹3,049.15	₹2,620.95	₹2,349.16	₹2,320.17

* All values are in INR Crore

Qty

Bid

599

1759.2

Ask

Qty

Bid Total: 599

Ask Total: 0

Buy orders: 100%

Sell orders: 0%

30 levels of bid & ask depth

Supply & Demand Zones

Bearish

Neutral

Bullish

Slightly Bullish

by SEBI experts available for this stock

Earn more using advisory

by SEBI experts

Expert Pick

EXPPICK

Stop-loss

Entry price

Target

Indicator

Value

Verdict

RSI (14)

53.08

Neutral

ATR (14)

48.83

Neutral

STOCH(9,6)

17.74

Bullish

STOCH RSI (14)

Bullish

ADX(9)

21.71

Bearish

UO(9)

40.62

Neutral

ROC(12)

0.37

Bullish

WillR(14)

-65.34

Neutral

Period

Simple value

Exponential vaue

1707.74

1717.55

10D

1715.18

1708.2

20D

1688.09

1691.14

50D

1646.57

1638.3

100D

1528.09

1578.79

About Dr. Lal Path Labs

ISIN

INE600L01024

Sector Market Cap

₹ 28,275.5 Cr

Dr. Lal PathLabs Limited is an India-based provider of diagnostic and related healthcare tests and services. The Company is engaged primarily in the business of running laboratories for carrying out pathological investigations in various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It offers a range of tests, including Pregnancy Test, Full Body Checkups, Covid 19 Test, Heart Test, Kidney Test, Liver Test, Cholesterol Test, Hepatitis B Test, Kidney Function Test, Sugar Test, Thyroid Test, Typhoid Test, Uric Acid Test, Vitamin B12 Test and vitamin D Test. It has approximately 298 clinical laboratories (including National Reference Lab at Delhi, Regional Reference Lab in Kolkata, Bangalore and Mumbai), 6,607 patient service centers, and 12,365 pick-up points (PUPs). Its customers include individual patients, hospitals, and corporate customers.

Dr. Lal Path Labs Financial Highlights

Revenue: Dr. Lal Path Labs reported revenue of ₹2,864.20 crore in FY26 vs ₹2,554.80 crore in FY25. It showed an increase of 12.11% on a yearly basis.
Operating Profit: Dr. Lal Path Labs reported an operating profit of ₹669.10 crore in FY26 vs ₹624.70 crore in FY25. It showed an increase of 7.11% on a year-on-year basis.
Net Profit: Dr. Lal Path Labs reported a net profit of ₹509.80 crore in FY26 vs ₹492.20 crore in FY25. It showed an increase of 3.58% on a yearly basis.

Dr. Lal Path Labs Quarterly Result Highlights

Dr. Lal Path Labs reported revenue of ₹829.60 crore in Jun 2026, compared with ₹726.70 crore in Mar 2026, representing an increase of 14.16% on a quarter-on-quarter (QoQ) basis.
Dr. Lal Path Labs reported an operating profit of ₹228.70 crore in Jun 2026, compared with ₹160.10 crore in Mar 2026, representing an increase of 42.85% on a quarter-on-quarter (QoQ) basis.
Dr. Lal Path Labs reported a profit of ₹170.50 crore in Jun 2026, compared with ₹132.20 crore in Mar 2026, reflecting an increase of 28.97% on a QoQ basis.
The earnings per share (EPS) of Dr. Lal Path Labs stood at ₹30.24 during Jun 2026.